Intl Medication Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INTL MEDICATION, and what generic and branded alternatives to INTL MEDICATION drugs are available?
INTL MEDICATION has fifty-seven approved drugs.
Summary for Intl Medication
| US Patents: | 0 |
| Tradenames: | 43 |
| Ingredients: | 39 |
| NDAs: | 57 |
Drugs and US Patents for Intl Medication
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intl Medication | BRETYLIUM TOSYLATE | bretylium tosylate | INJECTABLE;INJECTION | 070119-001 | Apr 29, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Intl Medication | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 087851-001 | Feb 9, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Intl Medication Sys | EPINEPHRINE | epinephrine | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 211880-001 | Apr 24, 2020 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
